基金经理：王峥娇
| 单位净值:2.0882 | 净值增长率:0.22% | 累计净值:2.3032 | 截止日期:2024/5/17 | ||
|---|---|---|---|---|---|
| 最新估值:-(-) | 涨跌幅:- | 涨跌额:- | |||
| 最新规模:0.16亿元 | 风险等级:风险 | 申购状态:可申购 | 赎回状态:可赎回 |
展开全部
- 基本资料
- 投资风格
- 基金财务状况
- 基金评级
单位(元)南方医药保健灵活配置混合C(014933)资产负债表 |
||||
|---|---|---|---|---|
| 报告期 | 2023/12/31 | 2023/6/30 | 2022/12/31 | 2022/6/30 |
| 资产 | ||||
| 银行存款 | 153,137,267 | 129,493,957 | 156,517,868 | 168,473,594 |
| 结算备付金 | 6,860,723 | 6,575,455 | 6,199,315 | 1,803,260 |
| 存出保证金 | 634,555 | 979,747 | 625,715 | 913,201 |
| 交易性金融资产 | 2,728,492,954 | 2,698,689,128 | 2,750,093,512 | 3,236,438,901 |
| 其中：股票投资 | 2,576,087,067 | 2,556,255,573 | 2,681,372,724 | 3,098,997,481 |
| 基金投资 | - | - | - | - |
| 债券投资 | 152,405,887 | 142,433,556 | 68,720,788 | 137,441,420 |
| 资产支持证券投资 | - | - | - | - |
| 衍生金融资产 | - | - | - | - |
| 买入返售金融资产 | 85,132,000 | - | - | - |
| 应收证券清算款 | - | 48,605,986 | - | - |
| 应收利息 | - | - | - | - |
| 应收股利 | - | - | - | - |
| 应收申购款 | 1,140,174 | 1,176,842 | 2,154,176 | 5,489,881 |
| 其他资产 | - | - | - | - |
| 资产总计 | 2,975,397,673 | 2,885,521,117 | 2,915,590,586 | 3,413,118,837 |
| 负债 | ||||
| 短期借款 | - | - | - | - |
| 交易性金融负债 | - | - | - | - |
| 衍生金融负债 | - | - | - | - |
| 卖出回购金融资产款 | - | - | - | - |
| 应付证券清算款 | 125,749,965 | 19,391,884 | - | 62,838,263 |
| 应付赎回款 | 3,810,390 | 3,592,355 | 4,994,947 | 9,978,131 |
| 应付管理人报酬 | 2,939,670 | 3,531,578 | 3,627,716 | 3,754,175 |
| 应付托管费 | 489,945 | 588,596 | 604,619 | 625,696 |
| 应付销售服务费 | 13,290 | 12,532 | 10,851 | 4,224 |
| 应付交易费用 | - | - | - | - |
| 应交税费 | 3 | 6 | - | 17 |
| 应付利息 | - | - | - | - |
| 应付利润 | - | - | - | - |
| 其他负债 | 3,392,895 | 4,211,751 | 3,910,498 | 1,651,173 |
| 负债合计 | 136,396,159 | 31,328,703 | 13,148,631 | 78,851,677 |
| 所有者权益 | ||||
| 实收基金 | 1,269,242,115 | 1,205,848,165 | 1,159,563,324 | 1,106,486,084 |
| 未分配利润 | 1,569,759,399 | 1,648,344,249 | 1,742,878,631 | 2,227,781,075 |
| 所有者权益合计 | 2,839,001,514 | 2,854,192,415 | 2,902,441,955 | 3,334,267,159 |
| 负债和所有者权益总计 | 2,975,397,673 | 2,885,521,117 | 2,915,590,586 | 3,413,118,837 |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。